I’m not giving my Kid an experimental drug

The FDA determined that a third Pfizer shot can boost protection for children in this age group and the benefits outweigh the risks, said Dr. Peter Marks, who heads the drug regulator's vaccine division.FDA Commissioner Robert Califf said although Covid tends to be less severe in children, more kids have been getting sick and hospitalized with virus since the omicron variant became dominant.The FDA did not convene its committee of independent experts before authorizing the booster dose.The Food and Drug Administration on Tuesday authorized a third shot of Pfizer's Covid vaccine for children ages 5 to 11 at least five months after their two-dose primary series.Dr. Peter Marks, head of the FDA division responsible for vaccines, said data increasingly shows that the protection provided by two shots wanes over time. The FDA determined that a third shot can help boost protection for children in this age group and the benefits outweigh the risks, Marks said.